Brain Metastases in Elderly Patients—The Role of Surgery in the Context of Systemic Treatment

In patients with brain metastases (BM), advanced age is considered a negative prognostic factor. To address the potential reasons for that, we assessed 807 patients who had undergone BM resection; 315 patients aged at least 65 years (group A) were compared with 492 younger patients (group B). We analyzed the impact of the pre- and postoperative Karnofsky performance status (KPS), postoperative treatment structure and post-treatment survival. BM resection significantly improved KPS scores in both groups (p = 0.0001). Median survival after BM resection differed significantly between the groups (A: 5.81 vs. B: 8.12 months; p = 0.0015). In both groups, patients who received postoperative systemic treatment showed significantly longer overall survival (p = 0.00001). However, elderly patients less frequently received systemic treatment (p = 0.0001) and the subgroup of elderly patients receiving such therapies had a significantly higher postsurgical KPS score (p = 0.0007). In all patients receiving systemic treatment, age was no longer a negative prognostic factor. Resection of BM improves the functional status of elderly patients, thus enhancing the likeliness to receive systemic treatment, which, in turn, leads to longer overall survival. In the context of such a treatment structure, age alone is no longer a prognostic factor for survival.

[1]  R. Goldbrunner,et al.  Surgical resection of symptomatic brain metastases improves the clinical status and facilitates further treatment , 2020, Cancer medicine.

[2]  C. Anders,et al.  Current multidisciplinary management of brain metastases , 2020, Cancer.

[3]  C. Printz Some elderly survivors of 3 common cancers have an increased risk of brain metastases , 2019, Cancer.

[4]  C. R. Goodwin,et al.  Operative and peri‐operative considerations in the management of brain metastasis , 2019, Cancer medicine.

[5]  J. Feliu,et al.  Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients , 2019, Clinical and Translational Oncology.

[6]  F. Schumacher,et al.  Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[7]  Timothy R. Smith,et al.  Survival and prognostic factors in surgically treated brain metastases , 2019, Journal of Neuro-Oncology.

[8]  D. Rodrigues,et al.  Analysis of survival in patients with brain metastases treated surgically: Impact of age, gender, oncologic status, chemotherapy, radiotherapy, number and localization of lesions, and primary cancer site. , 2018, Revista da Associacao Medica Brasileira.

[9]  J. Fiveash,et al.  Hospice care, cancer-directed therapy, and Medicare expenditures among older patients dying with malignant brain tumors , 2018, Neuro-oncology.

[10]  A. Frati,et al.  Multiple brain metastases: a surgical series and neurosurgical perspective , 2018, Neurological Sciences.

[11]  J. Lagergren,et al.  The Charlson Comorbidity Index in Registry-based Research , 2017, Methods of Information in Medicine.

[12]  M. Vega,et al.  Brain Metastases of Non–Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection , 2017, Journal of Neurological Surgery Part A: Central European Neurosurgery.

[13]  D. Jäger,et al.  Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma , 2016, Journal of Neuro-Oncology.

[14]  Adrian V. Lee,et al.  Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy , 2015, Cancer medicine.

[15]  A. Mahipal,et al.  Participation of the elderly population in clinical trials: barriers and solutions. , 2014, Cancer control : journal of the Moffitt Cancer Center.

[16]  Z. Ram,et al.  Outcome of Elderly Patients Undergoing Awake-Craniotomy for Tumor Resection , 2013, Annals of Surgical Oncology.

[17]  M. Proescholdt,et al.  Surgical Resection of Brain Metastases—Impact on Neurological Outcome , 2013, International journal of molecular sciences.

[18]  V. Esposito,et al.  Stereotactic radiosurgery in elderly patients with brain metastases , 2013, Journal of Neuro-Oncology.

[19]  Chae-Yong Kim,et al.  The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study , 2013, Acta Neurochirurgica.

[20]  Ronald C. Chen,et al.  Impact of age and comorbidity on treatment and outcomes in elderly cancer patients. , 2012, Seminars in radiation oncology.

[21]  H. Mehdorn,et al.  Surgical treatment for brain metastases: Prognostic factors and survival in 309 patients with regard to patient age , 2011, Journal of Clinical Neuroscience.

[22]  Walter Curran,et al.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. , 2008, International journal of radiation oncology, biology, physics.

[23]  S. Toms,et al.  RPA classification has prognostic significance for surgically resected single brain metastasis. , 2006, International journal of radiation oncology, biology, physics.

[24]  M. Sperling,et al.  Reevaluation of Surgery for the Treatment of Brain Metastases: Review of 208 Patients with Single or Multiple Brain Metastases Treated at One Institution with Modern Neurosurgical Techniques , 2005, Neurosurgery.

[25]  W. Ershler Cancer: a disease of the elderly. , 2003, The journal of supportive oncology.

[26]  D. Dale Poor prognosis in elderly patients with cancer: the role of bias and undertreatment. , 2003, The journal of supportive oncology.

[27]  Joy H. Lewis,et al.  Participation of patients 65 years of age or older in cancer clinical trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  C. Coltman,et al.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.

[29]  S. Howng,et al.  Prognostic analysis in patients of lung cancer with brain metastasis under surgical removal. , 1998, Kaohsiung Journal of Medical Sciences.

[30]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[31]  E. Chrischilles,et al.  Treatment Patterns and Survival of Elderly Patients With Breast Cancer Brain Metastases , 2019, American journal of clinical oncology.

[32]  P. Marchetti,et al.  Brain Metastases: Surgical Treatment and Overall Survival. , 2017, World neurosurgery.

[33]  M. Rossetto,et al.  Surgery on motor area metastasis , 2015, Neurosurgical Review.

[34]  E. Noordijk,et al.  The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. , 1994, International journal of radiation oncology, biology, physics.